Thus, considering our findings and those from the aforementioned studies, we can conclude that GNRI, calculated using both serum albumin level and weight, may be useful in clinical practice as an objective and inexpensive nutritional marker for monitoring CKD progression in patients with type 2 DM. Here, ALB is linked to chronic kidney disease.